Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma.
Dikkers
Frederik G
FG
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015197:Carcinogenicity Tests; D002277:Carcinoma / Q000139:chemically induced; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D036502:Infusions, Intralesional; D007822:Laryngeal Neoplasms / Q000139:chemically induced; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects*; D051381:Rats; D013723:Teratogens
D000970:Antineoplastic Agents; D063065:Organophosphonates; D013723:Teratogens; D003596:Cytosine; D000077404:Cidofovir